CORRECTION article

Front. Cell Dev. Biol., 25 August 2022

Sec. Epigenomics and Epigenetics

Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.1009752

Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis

  • 1. Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, China

  • 2. Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China

Article metrics

View details

1,5k

Views

1k

Downloads

In the original article there was a mistake in the author affiliations for Xiulin Jiang which was erroneously presented as “Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China”, it should instead be “Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

m6A modification, SNHG1, miRNA-140-3p, UBE2C, pan-cancer, prognosis, immune cell infiltration, drug sensitivity

Citation

Jiang X, Yuan Y, Tang L, Wang J, Liu Q, Zou X and Duan L (2022) Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis. Front. Cell Dev. Biol. 10:1009752. doi: 10.3389/fcell.2022.1009752

Received

02 August 2022

Accepted

03 August 2022

Published

25 August 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2022

Updates

Copyright

*Correspondence: Lincan Duan,

†These authors have contributed equally to this work

This article was submitted to Epigenomics and Epigenetics, a section of the journal Frontiers in Cell and Developmental Biology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics